Sclerosing epithelioid mesenchymal neoplasm of the pancreas – A proposed new entity Journal Article


Authors: Basturk, O.; Weigelt, B.; Adsay, V.; Benhamida, J. K.; Askan, G.; Wang, L.; Arcila, M. E.; Zamboni, G.; Fukushima, N.; Gularte-Mérida, R.; Da Cruz Paula, A.; Selenica, P.; Kumar, R.; Pareja, F.; Maher, C. A.; Scholes, J.; Oda, Y.; Santini, D.; Doyle, L. A.; Petersen, I.; Flucke, U.; Koelsche, C.; Reynolds, S. J.; Yavas, A.; von Deimling, A.; Reis-Filho, J. S.; Klimstra, D. S.
Article Title: Sclerosing epithelioid mesenchymal neoplasm of the pancreas – A proposed new entity
Abstract: We have encountered pancreatic tumors with unique histologic features, which do not conform to any of the known tumors of the pancreas or other anatomical sites. We aimed to define their clinicopathologic features and whether they are characterized by recurrent molecular signatures. Eight cases were identified; studied histologically and by immunohistochemistry. Selected cases were also subjected to whole-exome sequencing (WES; n = 4), RNA-sequencing (n = 6), Archer FusionPlex assay (n = 5), methylation profiling using the Illumina MethylationEPIC (850k) array platform (n = 6), and TERT promoter sequencing (n = 5). Six neoplasms occurred in females. The mean age was 43 years (range: 26–75). Five occurred in the head/neck of the pancreas. All patients were treated surgically; none received neoadjuvant/adjuvant therapy. All patients are free of disease after 53 months of median follow-up (range: 8–94). The tumors were well-circumscribed, and the median size was 1.8 cm (range: 1.3–5.8). Microscopically, the unencapsulated tumors had a geographic pattern of epithelioid cell nests alternating with spindle cell fascicles. Some areas showed dense fibrosis, in which enmeshed tumor cells imparted a slit-like pattern. The predominant epithelioid cells had scant cytoplasm and round-oval nuclei with open chromatin. The spindle cells displayed irregular, hyperchromatic nuclei. Mitoses were rare. No lymph node metastases were identified. All tumors were positive for vimentin, CD99 and cytokeratin (patchy), while negative for markers of solid pseudopapillary neoplasm, neuroendocrine, acinar, myogenic/rhabdoid, vascular, melanocytic, or lymphoid differentiation, gastrointestinal stromal tumor as well as MUC4. Whole-exome sequencing revealed no recurrent somatic mutations or amplifications/homozygous deletions in any known oncogenes or tumor suppressor genes. RNA-sequencing and the Archer FusionPlex assay did not detect any recurrent likely pathogenic gene fusions. Single sample gene set enrichment analysis revealed that these tumors display a likely mesenchymal transcriptomic program. Unsupervised analysis (t-SNE) of their methylation profiles against a set of different mesenchymal neoplasms demonstrated a distinct methylation pattern. Here, we describe pancreatic neoplasms with unique morphologic/immunophenotypic features and a distinct methylation pattern, along with a lack of abnormalities in any of key genetic drivers, supporting that these neoplasms represent a novel entity with an indolent clinical course. Given their mesenchymal transcriptomic features, we propose the designation of “sclerosing epithelioid mesenchymal neoplasm” of the pancreas. © 2019, United States & Canadian Academy of Pathology.
Keywords: immunohistochemistry; adult; clinical article; protein expression; aged; methylation; promoter region; somatic mutation; gene deletion; clinical feature; disease course; follow up; gastrointestinal stromal tumor; tumor volume; telomerase; histology; tumor suppressor gene; pancreas tumor; gene fusion; spindle cell; protein s 100; cd99 antigen; cytokeratin ae1; cytokeratin ae3; cytokeratin 18; vimentin; mucin 4; human; male; female; priority journal; article; rna sequencing; whole exome sequencing; sclerosing epithelioid mesenchymal neoplasm of the pancreas
Journal Title: Modern Pathology
Volume: 33
Issue: 3
ISSN: 0893-3952
Publisher: Nature Research  
Date Published: 2020-03-01
Start Page: 456
End Page: 467
Language: English
DOI: 10.1038/s41379-019-0334-5
PUBMED: 31383964
PROVIDER: scopus
PMCID: PMC7000300
DOI/URL:
Notes: Article -- Export Date: 1 April 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Olca Basturk
    352 Basturk
  2. David S Klimstra
    978 Klimstra
  3. Lu Wang
    147 Wang
  4. Maria Eugenia Arcila
    657 Arcila
  5. Britta Weigelt
    632 Weigelt
  6. Gokce Askan
    77 Askan
  7. Pier Selenica
    189 Selenica
  8. Rahul Kumar
    23 Kumar
  9. Aslihan Yavas
    11 Yavas